Drug Search Results
More Filters [+]

DNB-001

Alternative Names: dnb-001, dnb001, dnb 001
Latest Update: 2009-06-03
Latest Update Note: Clinical Trial Update

Product Description

For intraocular Hypertension

Mechanisms of Action: Ion Channel Modulator

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Danube
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for DNB-001

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Angina Pectoris|Kidney Diseases|Hypertension|Glaucoma

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

2007-002208-17

P2

Active, not recruiting

Angina Pectoris|Kidney Diseases

2008-12-14

DNB-001

P2

Completed

Glaucoma|Hypertension

2008-08-01

2006-003907-38

P2

Terminated

Hypertension

2007-12-12

Recent News Events

Date

Type

Title